Universal Health Services, Inc. logo UHS - Universal Health Services, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 18
HOLD 23
SELL 2
STRONG
SELL
0
| PRICE TARGET: $207.57 DETAILS
HIGH: $310.00
LOW: $165.00
MEDIAN: $194.00
CONSENSUS: $207.57
UPSIDE: 34.74%

Stock News

UNIVERSAL HEALTH SERVICES, INC. INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services, Inc.'s Directors and Officers for Breach of Fiduciary Duties - UHS

UNIVERSAL HEALTH SERVICES, INC. INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services, Inc.'s Directors and Officers for Breach of Fiduciary Duties - UHS

New York, New York--(Newsfile Corp. - June 11, 2026) - Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Universal Health Services, Inc. (NYSE: UHS) failed to manage Universal Health in an acceptable manner, breaching their fiduciary duties to Universal Health, and whether Universal Health and its shareholders have suffered damages as a result. Attorney Joseph A.

Jun 11, 2026 04:00 AM newsfilecorp.com (Hide legal announcements)
UNIVERSAL HEALTH SERVICES, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services, Inc.'s Directors and Officers for Breach of Fiduciary Duties - UHS

UNIVERSAL HEALTH SERVICES, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services, Inc.'s Directors and Officers for Breach of Fiduciary Duties - UHS

New York, New York--(Newsfile Corp. - May 28, 2026) - Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Universal Health Services, Inc. (NYSE: UHS) failed to manage Universal Health in an acceptable manner, breaching their fiduciary duties to Universal Health, and whether Universal Health and its shareholders have suffered damages as a result. Attorney Joseph A.

May 28, 2026 01:00 PM newsfilecorp.com (Hide legal announcements)
First Eagle U.S. Fund Q1 2026 Portfolio Review

First Eagle U.S. Fund Q1 2026 Portfolio Review

U.S. Fund A Shares (without sales charge*) posted a return of 1.17% in first quarter 2026. Leading contributors in the First Eagle U.S. Fund this quarter included gold bullion, Exxon Mobil Corporation, Noble Corporation PLC Class A, IPG Photonics Corporation and SLB Limited. The leading detractors in the quarter were Workday, Inc. Class A, Oracle Corporation, Salesforce.com, Inc., Meta Platforms, Inc. Class A and Universal Health Services, Inc, Class B.

May 04, 2026 08:32 AM seekingalpha.com

Price Targets